{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:31:28Z","timestamp":1792794688053,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T00:00:00Z","timestamp":1593302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","award":["NIHR-RP-2014-04-026"],"award-info":[{"award-number":["NIHR-RP-2014-04-026"]}],"id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Collaborations for Leadership in Applied Health Research and Care West Midlands","id":[{"id":"https:\/\/ror.org\/021954z67","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013374","name":"NIHR School for Primary Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772413"],"award-info":[{"award-number":["81772413"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702207"],"award-info":[{"award-number":["81702207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702206"],"award-info":[{"award-number":["81702206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930071"],"award-info":[{"award-number":["81930071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Project","award":["2018YFB1105705"],"award-info":[{"award-number":["2018YFB1105705"]}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"crossref","award":["2019RS2010"],"award-info":[{"award-number":["2019RS2010"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Research and Development Program of Hunan Province","award":["2018SK2070"],"award-info":[{"award-number":["2018SK2070"]}]},{"name":"Key Research and Development Program of Hunan Province","award":["2018SK2071"],"award-info":[{"award-number":["2018SK2071"]}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine trends in the initial prescription of commonly-prescribed analgesics and patient- as well as practice-level factors related to their selection in incident OA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients consulting with incident clinical OA between 2000\u20132016 were identified within The Health Improvement Network in the United Kingdom (UK) general practice. Excluded were patients who had history of cancer or were prescribed the analgesics of interest within 6 months before diagnosis of OA. Initial analgesic prescription included oral non-selective NSAID, oral selective cyclooxygenase-2 inhibitor, topical NSAID, paracetamol, topical salicylate or oral\/transdermal opioid within 1 month after OA diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\u223c44% of patients with incident OA (n\u2009=\u2009125\u00a0696) were prescribed one of these analgesics. Incidence of oral NSAID prescriptions decreased whereas other analgesic prescriptions, including oral opioid prescriptions, increased (all P-for-trend\u2009&amp;lt;\u20090.001). Patients with a history of gastrointestinal disease were more likely to receive topical NSAIDs, paracetamol or oral\/transdermal opioids. Only 38% of patients with history of gastrointestinal disease and 21% of patients without it had co-prescription of gastroprotective agent with oral NSAIDs. Oral\/transdermal opioid prescription was higher among the elderly (\u226565\u2009years), women, obesity, current smoker, and patients with gastrointestinal, cardiovascular or chronic kidney disease. Prescription of oral opioids increased with social deprivation (P-for-trend\u2009&amp;lt;\u20090.05) and was highest in Scotland, whereas transdermal opioid prescription was highest in Northern Ireland (all P-for-homogeneity-test\u2009&amp;lt;\u20090.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The initial prescription pattern of analgesics for OA has changed over time in the UK. Co-prescription of gastroprotective agents with oral NSAIDs remains suboptimal, even among those with prior gastrointestinal disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa244","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T07:10:12Z","timestamp":1591254612000},"page":"147-159","source":"Crossref","is-referenced-by-count":38,"title":["Initial analgesic prescriptions for osteoarthritis in the United Kingdom, 2000\u20132016"],"prefix":"10.1093","volume":"60","author":[{"given":"Chao","family":"Zeng","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China"},{"name":"Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital"},{"name":"The Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiya","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham"},{"name":"Pain Centre Versus Arthritis UK, Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Doherty","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham"},{"name":"Pain Centre Versus Arthritis UK, Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica S M","family":"Persson","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham"},{"name":"Pain Centre Versus Arthritis UK, Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mallen","sequence":"additional","affiliation":[{"name":"Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Keele, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9207-1065","authenticated-orcid":false,"given":"Subhashisa","family":"Swain","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham"},{"name":"Pain Centre Versus Arthritis UK, Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Li","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Joint Degeneration and Injury"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wei","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital"},{"name":"The Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"Health Management Center, Xiangya Hospital, Central South University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China"},{"name":"Hunan Key Laboratory of Joint Degeneration and Injury"},{"name":"Hunan Engineering Research Center of Osteoarthritis, Changsha, China"},{"name":"National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital"},{"name":"The Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,28]]},"reference":[{"key":"2021010517013138700_keaa244-B1","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet"},{"key":"2021010517013138700_keaa244-B2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41584-019-0221-y","article-title":"Therapeutic options for targeting inflammatory osteoarthritis pain","volume":"15","author":"Conaghan","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2021010517013138700_keaa244-B3","year":"2014"},{"key":"2021010517013138700_keaa244-B4","first-page":"2002","article-title":"Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial","volume":"31","author":"Tugwell","year":"2004","journal-title":"J Rheumatol"},{"key":"2021010517013138700_keaa244-B5","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/ard.2006.065128","article-title":"Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial","volume":"66","author":"Rother","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2021010517013138700_keaa244-B6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pain.2009.03.008","article-title":"Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis","volume":"143","author":"Simon","year":"2009","journal-title":"Pain"},{"key":"2021010517013138700_keaa244-B7","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2","volume":"296","author":"McGettigan","year":"2006","journal-title":"JAMA"},{"key":"2021010517013138700_keaa244-B8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs","volume":"115","author":"Gabriel","year":"1991","journal-title":"Ann Intern Med"},{"key":"2021010517013138700_keaa244-B9","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S0140-6736(17)31744-0","article-title":"Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis","volume":"390","author":"da Costa","year":"2017","journal-title":"Lancet"},{"key":"2021010517013138700_keaa244-B10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/annrheumdis-2014-206914","article-title":"Paracetamol: not as safe as we thought? A systematic literature review of observational studies","volume":"75","author":"Roberts","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021010517013138700_keaa244-B11","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1136\/ard.2011.154047","article-title":"A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen\/paracetamol in community-derived people with knee pain","volume":"70","author":"Doherty","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021010517013138700_keaa244-B12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1572-0241.2008.01811.x","article-title":"Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada","volume":"103","author":"Rahme","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"2021010517013138700_keaa244-B13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.canep.2016.06.009","article-title":"Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink","volume":"43","author":"Yang","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"2021010517013138700_keaa244-B14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.2019.1347","article-title":"Association of tramadol with all-cause mortality among patients with osteoarthritis","volume":"321","author":"Zeng","year":"2019","journal-title":"JAMA"},{"key":"2021010517013138700_keaa244-B15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/acr.22360","article-title":"Trends in prescription of opioids from 2003-2009 in persons with knee osteoarthritis","volume":"66","author":"Wright","year":"2014","journal-title":"Arthritis Care Res"},{"key":"2021010517013138700_keaa244-B16","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/rheumatology\/kex270","article-title":"Population trends in the incidence and initial management of osteoarthritis: age-period-cohort analysis of the Clinical Practice Research Datalink, 1992-2013","volume":"56","author":"Yu","year":"2017","journal-title":"Rheumatology"},{"key":"2021010517013138700_keaa244-B17","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2018.0899","article-title":"Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial","volume":"319","author":"Krebs","year":"2018","journal-title":"JAMA"},{"key":"2021010517013138700_keaa244-B18","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"Blak","year":"2011","journal-title":"Inform Prim Care"},{"key":"2021010517013138700_keaa244-B19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2021010517013138700_keaa244-B20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1053\/j.gastro.2017.10.042","article-title":"No increase in risk of acute myocardial infarction in privately insured adults prescribed proton pump inhibitors vs histamine-2 receptor antagonists (2002-2014)","volume":"154","author":"Landi","year":"2018","journal-title":"Gastroenterology"},{"key":"2021010517013138700_keaa244-B21","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2017.07.763","article-title":"Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women","volume":"70","author":"Caleyachetty","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"2021010517013138700_keaa244-B22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/pds.2203","article-title":"Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease","volume":"20","author":"Denburg","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2021010517013138700_keaa244-B23","first-page":"318","article-title":"Which deprivation? A comparison of selected deprivation indexes","volume":"13","author":"Morris","year":"1991","journal-title":"J Public Health Med"},{"key":"2021010517013138700_keaa244-B24","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/bmj.319.7212.738","article-title":"Quality at general practice consultations: cross sectional survey","volume":"319","author":"Howie","year":"1999","journal-title":"BMJ"},{"key":"2021010517013138700_keaa244-B25","doi-asserted-by":"crossref","first-page":"k3426","DOI":"10.1136\/bmj.k3426","article-title":"Diclofenac use and cardiovascular risks: series of nationwide cohort studies","volume":"362","author":"Schmidt","year":"2018","journal-title":"BMJ"},{"key":"2021010517013138700_keaa244-B26","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/S0140-6736(17)30981-9","article-title":"Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial","volume":"389","author":"Chan","year":"2017","journal-title":"Lancet"},{"key":"2021010517013138700_keaa244-B27","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"375","author":"Nissen","year":"2016","journal-title":"N Engl J Med"},{"key":"2021010517013138700_keaa244-B28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.joca.2015.10.006","article-title":"Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities","volume":"24","author":"Katz","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"key":"2021010517013138700_keaa244-B29","doi-asserted-by":"crossref","first-page":"b2538","DOI":"10.1136\/bmj.b2538","article-title":"Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis","volume":"339","author":"Latimer","year":"2009","journal-title":"BMJ"},{"key":"2021010517013138700_keaa244-B30","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/bjsports-2017-098043","article-title":"Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies","volume":"52","author":"Zeng","year":"2018","journal-title":"Br J Sports Med"},{"key":"2021010517013138700_keaa244-B31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bmj.311.6996.22","article-title":"Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study","volume":"311","author":"Evans","year":"1995","journal-title":"BMJ"},{"key":"2021010517013138700_keaa244-B32","doi-asserted-by":"crossref","first-page":"006874","DOI":"10.1161\/JAHA.117.006874","article-title":"Comparative risk of cardiovascular outcomes between topical and oral nonselective NSAIDs in Taiwanese patients with rheumatoid arthritis","volume":"6","author":"Lin","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2021010517013138700_keaa244-B33","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.joca.2016.01.135","article-title":"Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review","volume":"24","author":"Smith","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"key":"2021010517013138700_keaa244-B34","year":"2019"},{"key":"2021010517013138700_keaa244-B35","year":"2013"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/1\/147\/35433607\/keaa244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/1\/147\/35433607\/keaa244.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T03:08:14Z","timestamp":1610248094000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/1\/147\/5864220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,6,28]]},"published-print":{"date-parts":[[2021,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa244","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1]]},"published":{"date-parts":[[2020,6,28]]}}}